Naim Ata
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
-
- Atrial Fibrillation Management and Outcomes
- Antiplatelet Therapy and Cardiovascular Diseases
Papers in
-
- Heart Failure Treatment and Management 11
-
- COVID-19 Clinical Research Studies 19
- Co-authors
- Derun Taner Ertuğrul (32 shared papers)Bünyamin Yavuz (18 shared papers)Metin Küçükazman (17 shared papers)Ahmet Arif Yalçın (12 shared papers)Kadir Okhan Akın (13 shared papers)Kürşat Dal (22 shared papers)Şuayıp Birinci (57 shared papers)Osman Çelik (25 shared papers)
- Journals
- Clinical and Experimental Hypertension (2 papers)Atherosclerosis (2 papers)BMC Musculoskeletal Disorders (2 papers)Injury (2 papers)Multiple Sclerosis and Related Disorders (2 papers)
- Partner nations
- TürkiyeUnited StatesUnited Kingdom
In The Last Decade
Naim Ata
90 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 84
- Infectious Diseases 332
- Cardiology and Cardiovascular Medicine 337
- Geriatrics and Gerontology 42
- Pathology and Forensic Medicine 162
- Endocrinology, Diabetes and Metabolism 132
Countries citing papers authored by Naim Ata
This map shows the geographic impact of Naim Ata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naim Ata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naim Ata more than expected).
Fields of papers citing papers by Naim Ata
This network shows the impact of papers produced by Naim Ata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naim Ata. The network helps show where Naim Ata may publish in the future.
Co-authors
The 25 scholars most cited alongside Naim Ata, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 105 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 173 | |
| 2 | 2009 | 102 | |
| 3 | 2020 | 99 | |
| 4 | 2010 | 72 | |
| 5 | 2010 | 70 | |
| 6 | 2020 | 67 | |
| 7 | 2010 | 60 | |
| 8 | High-sensitivity C-reactive protein is a strong predictor of non-alcoholic fatty liver disease. | 2014 | 54 |
| 9 | 2020 | 53 | |
| 10 | 2005 | 46 | |
| 11 | 2011 | 42 | |
| 12 | 2012 | 34 | |
| 13 | 2020 | 34 | |
| 14 | 2021 | 32 | |
| 15 | 2020 | 29 | |
| 16 | 2020 | 26 | |
| 17 | 2015 | 23 | |
| 18 | 2014 | 22 | |
| 19 | 2023 | 22 | |
| 20 | 2008 | 20 |
About Naim Ata
Naim Ata is a scholar working on Cardiology and Cardiovascular Medicine, Infectious Diseases, Pathology and Forensic Medicine, Endocrinology, Diabetes and Metabolism and Surgery, having authored 105 papers that have together received 1.5k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (19 papers), Heart Failure Treatment and Management (11 papers), Vitamin D Research Studies (7 papers), COVID-19 and healthcare impacts (6 papers), Liver Disease Diagnosis and Treatment (5 papers), Bone health and osteoporosis research (4 papers), Thyroid Disorders and Treatments (4 papers) and Multiple Sclerosis Research Studies (3 papers). The work is most often cited by research in Infectious Diseases (332 citations), Cardiology and Cardiovascular Medicine (337 citations), Geriatrics and Gerontology (42 citations), Pathology and Forensic Medicine (162 citations) and Endocrinology, Diabetes and Metabolism (132 citations). Naim Ata has collaborated with scholars based in Türkiye, United States and United Kingdom. Frequent co-authors include Derun Taner Ertuğrul, Bünyamin Yavuz, Metin Küçükazman, Ahmet Arif Yalçın, Kadir Okhan Akın, Kürşat Dal, Şuayıp Birinci, Osman Çelik, Onur Sinan Deveci and Mustafa Mahir Ülgü. Their work appears in journals such as Clinical and Experimental Hypertension, Atherosclerosis, BMC Musculoskeletal Disorders, Injury and Multiple Sclerosis and Related Disorders.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.